Moderna Inc (NASDAQ:MRNA)
| 68.99 Delayed Data As of May 22 |  +1.94 / +2.89%Today’s Change | 11.54 Today|||52-Week Range 87.00 | +252.71% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 67.05 |
| Today’s open | 69.97 |
| Day’s range | 67.14 - 70.59 |
| Volume | 905,964 |
| Average volume (3 months) | 17,287,316 |
| Market cap | $26.7B |
Data as of 5:25pm ET, 05/22/2020
Growth & Valuation
| Earnings growth (last year) | +68.63% |
| Earnings growth (this year) | +5.10% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | -55.42% |
| P/E ratio | NM |
| Price/Sales | 107.47 |
| Price/Book | 19.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | +2.65 | +2.79% |
| EXASExact Sciences Corp | +0.49 | +0.59% |
| NBIXNeurocrine Bioscienc... | +3.72 | +3.07% |
| TECHBio-Techne Corp | -0.41 | -0.15% |
Data as of 4:00pm ET, 05/22/2020
Financials
| Next reporting date | August 5, 2020 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $60.2M |
| Annual profit (last year) | -$514.0M |
| Net profit margin | -853.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
